Načítá se...
Naltrexone for impulse control disorders in Parkinson disease: A placebo-controlled study
OBJECTIVE: Impulse control disorders (ICDs) in Parkinson disease (PD) are common and can be difficult to manage. The objective of this study was to determine the efficacy and tolerability of naltrexone, an opioid antagonist, for the treatment of ICDs in PD. METHODS: Patients with PD (n = 50) and an...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Lippincott Williams & Wilkins
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4155050/ https://ncbi.nlm.nih.gov/pubmed/25037206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000000729 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|